Alzheimer's Disease: NSC001 Medication Study

We are investigating the safety and tolerability of a new medication, NSC001, for people with mild to moderate Alzheimer's disease. This study will help us learn more about how the medication works in the body.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Trospium Aristo
Trospium Aristo is a medicine that helps control an overactive bladder, reducing sudden urges, frequent urination, and accidental urine leakage.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Trospium Chloride
Trospium chloride is a substance that relaxes the bladder to reduce urgent, frequent, or leaking urination from an overactive bladder.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Thia
8-Diazaspirodecane

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Ceris
Chlorure De Trospium Viatris
Cloreto De Tróspio Farmoz

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
University Hospital Graz
Klinische Abteilung für Neurogeriatrie
Graz, Austria
Medizinische Universitaet Innsbruck
Universitätsklinik für Neurologie
Innsbruck, Austria
Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH
Christian Doppler Clinic
Salzburg, Austria

Sponsor: Nsc Therapeutics GmbH
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.